We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
376 hedge funds and large institutions have $6.62B invested in Intra-Cellular Therapies Inc. in 2024 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 143 increasing their positions, 127 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
77% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 43
13% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 127
9% more funds holding
Funds holding: 346 → 376 (+30)
8% more capital invested
Capital invested by funds: $6.15B → $6.62B (+$469M)
9% more call options, than puts
Call options by funds: $28.9M | Put options by funds: $26.5M
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
Holders
376
Holders Change
+30
Holders Change %
+8.67%
% of All Funds
5.43%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
76
Increased
143
Reduced
127
Closed
43
Calls
$28.9M
Puts
$26.5M
Net Calls
+$2.4M
Net Calls Change
-$215M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$116M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$79.2M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$72.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$59.9M |
| 5 |
PA
Perceptive Advisors
New York
|
+$45.8M |
Top Sellers
| 1 |
BlackRock
New York
|
-$122M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$31.3M |
| 3 |
State Street
Boston,
Massachusetts
|
-$30.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$28.4M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$26.3M |
